1
项与 Anti-CD19 chimeric antigen receptor T cell therapy(Wuhan Sian Medical Technology Co., Ltd) 相关的临床试验A phase II study of indigenously manufacturedHCAR19 (2nd generation Anti-CD19-4-1BB-CD3? chimeric antigen receptor T-celltherapy) in adolescent and adult patients with relapsed/refractory B-cell malignancies
100 项与 Anti-CD19 chimeric antigen receptor T cell therapy(Wuhan Sian Medical Technology Co., Ltd) 相关的临床结果
100 项与 Anti-CD19 chimeric antigen receptor T cell therapy(Wuhan Sian Medical Technology Co., Ltd) 相关的转化医学
100 项与 Anti-CD19 chimeric antigen receptor T cell therapy(Wuhan Sian Medical Technology Co., Ltd) 相关的专利(医药)
100 项与 Anti-CD19 chimeric antigen receptor T cell therapy(Wuhan Sian Medical Technology Co., Ltd) 相关的药物交易